SEC EDGAR published this disclosure on 2026-08-03. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001940272-26-000013
acquired disposedA
codeP
direct or indirectI
form4
is derivativefalse
issuer nameNextCure, Inc.
labelOpen market purchase
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001940272-26-000013",
"acquired_disposed": "A",
"code": "P",
"direct_or_indirect": "I",
"form": "4",
"is_derivative": false,
"issuer_name": "NextCure, Inc.",
"label": "Open market purchase",
"person_name": "Schneeberger Daniel",
"price": 4.9556,
"role": "10% Owner",
"security": "Common Stock",
"shares": 77850,
"shares_owned_after": 686116,
"source_path": "edgar/data/1940272/0001940272-26-000013.txt",
"ticker": "NXTC",
"value": 385793.46
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.